IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26 FDA's decision follows positive Phase 1 results for GT-02287 in both healthy ...
Asianet Newsable on MSN
NeOnc Technologies receives UAE IND approval for NEO100, expanding global development ahead of anticipated phase 2 data milestone
Authorization covers all three NEO100 programs across adult Phase 1 through Phase 2, plus pediatric studies< Extends NeOnc’s ...
Early-phase clinical trials are undergoing a quiet but consequential transformation. Once considered a relatively narrow checkpoint focused on basic safety and tolerability, these early-phase studies ...
BOULDER, Colo., Dec. 11, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results